Abbott Laboratories (XSWX:ABT) Debt-to-Equity : 0.41 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Debt-to-Equity?

Abbott Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF934 Mil. Abbott Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF12,581 Mil. Abbott Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF33,384 Mil. Abbott Laboratories's debt to equity for the quarter that ended in Dec. 2023 was 0.40.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Abbott Laboratories's Debt-to-Equity or its related term are showing as below:

XSWX:ABT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.36 Med: 0.57 Max: 1.07
Current: 0.41

During the past 13 years, the highest Debt-to-Equity Ratio of Abbott Laboratories was 1.07. The lowest was 0.36. And the median was 0.57.

XSWX:ABT's Debt-to-Equity is ranked worse than
67.32% of 710 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XSWX:ABT: 0.41

Abbott Laboratories Debt-to-Equity Historical Data

The historical data trend for Abbott Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Debt-to-Equity Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.61

0.60

0.53

0.48

0.41

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.46	0.45	0.41	0.41	N/A

Competitive Comparison of Abbott Laboratories's Debt-to-Equity

For the Medical Devices subindustry, Abbott Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Debt-to-Equity falls into.

Abbott Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Abbott Laboratories's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(933.984	+	12581.11)	/	33383.874
	=	0.40

Abbott Laboratories's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(933.984	+	12581.11)	/	33383.874
	=	0.40

Abbott Laboratories (XSWX:ABT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Abbott Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (XSWX:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.